Table 2.
Baseline characteristics of subset patient’s population.
| CP-noAMI | CP-AMI | Statistical analysis | |
|---|---|---|---|
| No of cases, n (%) | 45 (84.9) | 8 (15.1) | |
| GENDER | |||
| Male, n (%) | 24 (53.3) | 5 (62.5) | n.s (Chi Square) |
| Female, n (%) | 21 (46.7) | 3 (37.5) | |
| AGE, median (range) | 72 (29–83) | 74 (53–86) | n.s (Mann-Whitney/Wilcoxon) |
| RDW, mean ± sd | 14 ± 1 | 13 ± 1 | n.s (Student t test) |
| MPV, mean ± sd | 9 ± 2 | 8 ± 2 | n.s (Student t test) |
| GLYCEMIA, mean ± sd | 118 ± 37 | 144 ± 62 | n.s (Mann-Whitney/Wilcoxon) |
| Time of symptom onset, mean ± sd | 25 ± 41 | 23 ± 31 | n.s (Student t test) |
| Pharmacological treatment | |||
| Pts on anti-PLT drugs, n (%) | 12 (31.6) | 3 (42.8) | n.s (Chi Square) |
| Pts not on anti-PLT drugs, n (%) | 26 (68.4) | 4 (57.2) | |
n: number; Pts: patients; RDW: Red Cell Distribution Width; MPV: mean platelet volume; sd: standard deviation; n.s: no statistical significance.